BMO Capital Maintains Outperform on Legence, Raises Price Target to $63

BMO Capital analyst Devin Dodge has maintained an 'Outperform' rating on Legence (NASDAQ: LGN) and increased the price target from $46 to $63. This adjustment reflects a positive outlook for the company's performance in the market.